Mechanisms of resistance to imatinib mesylate

被引：0
|
作者：
Roche-Lestienne, Catherine [1 ,2 ]
Preudhomme, Claude [1 ,3 ]
机构：
[1] Inst Rech Canc Lille, Unite Inserm 817, 1 Pl Verdun, F-59045 Lille, France
[2] Hop Jeanne Flandre, CHRU Lille, Lab Genel Med, F-59037 Lille, France
[3] Hop Albert Calmette, CHRU Lille, Lab Hematol A, F-59037 Lille, France
来源：
HEMATOLOGIE | 2006年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：11 / 18
页数：8
相关论文
共 50 条
  • [1] Molecular mechanisms of resistance of leukemia to imatinib mesylate
    Tauchi, T
    Ohyashiki, K
    LEUKEMIA RESEARCH, 2004, 28 : S39 - S45
  • [2] Mechanisms of resistance to imatinib mesylate in Bcr-Abl-positive leukemias
    Nimmanapalli, R
    Bhalla, K
    CURRENT OPINION IN ONCOLOGY, 2002, 14 (06) : 616 - 620
  • [3] Mechanisms of resistance to imatinib mesylate in KIT-positive metastatic uveal melanoma
    Calipel, Armelle
    Landreville, Solange
    De La Fouchardiere, Arnaud
    Mascarelli, Frederic
    Rivoire, Michel
    Penel, Nicolas
    Mouriaux, Frederic
    CLINICAL & EXPERIMENTAL METASTASIS, 2014, 31 (05) : 553 - 564
  • [4] Mechanisms of resistance to imatinib mesylate in KIT-positive metastatic uveal melanoma
    Armelle Calipel
    Solange Landreville
    Arnaud De La Fouchardière
    Frédéric Mascarelli
    Michel Rivoire
    Nicolas Penel
    Frédéric Mouriaux
    Clinical & Experimental Metastasis, 2014, 31 : 553 - 564
  • [5] Imatinib mesylate resistance and mutations: An Indian experience
    Srivastava, Shweta
    Dutt, Sarjana
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2013, 34 (03) : 213 - 220
  • [6] Recent advances about imatinib mesylate resistance
    Roche-Lestienne, Catherine
    Preudhomme, Claude
    HEMATOLOGIE, 2007, 13 (01): : 43 - 53
  • [7] Resistance to imatinib mesylate in chronic myeloid leukaemia
    Melo, Junia V.
    Chuah, Charles
    CANCER LETTERS, 2007, 249 (02) : 121 - 132
  • [8] INVOLVEMENT OF HEME OXYGENASE 1 IN THE MECHANISMS OF RESISTANCE TO IMATINIB MESYLATE IN CHRONIC MYELOID LEUKEMIA CELLS
    Tibullo, D.
    Barbagallo, I.
    Giallongo, C.
    Parrinello, N.
    La Cava, P.
    Vanella, L.
    Palumbo, G.
    Stagno, F.
    Li Volti, G.
    Di Raimondo, F.
    HAEMATOLOGICA, 2012, 97 : 69 - 69
  • [9] Understanding the molecular basis of imatinib mesylate therapy in chronic myelogenous leukemia and the related mechanisms of resistance
    Marcucci, G
    Perrotti, D
    Caligiuri, MA
    CLINICAL CANCER RESEARCH, 2003, 9 (04) : 1248 - 1252
  • [10] Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants
    Debiec-Rychter, M
    Cools, J
    Dumez, H
    Sciot, R
    Stul, M
    Mentens, N
    Vranckx, H
    Wasag, B
    Prenen, H
    Roesel, J
    Hagemeijer, A
    Van Oosterom, A
    Marynen, P
    GASTROENTEROLOGY, 2005, 128 (02) : 270 - 279
12345